Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiajian Zhujingfang
- Development stage
- Unknown
- Administration
- Oral
01
Overview
Jiajian Zhujingfang is a traditional Chinese medicine (TCM) formulation evaluated for its efficacy and safety in the treatment of pathological myopia-related choroidal neovascularization (PM-CNV). It is used as an adjunct or alternative therapy in TCM practice, but detailed information about its specific herbal composition, mechanism of action, or pharmacological targets is not available from the provided sources. The formulation appears to be under clinical investigation for ophthalmic indications related to myopic complications[2].
- Brand names
- Jiajian Zhujingfang
- Other names
- Modified Zhujing FormulaJiajian Zhujing FormulaJiajian Zhujing Decoction
02
Targets
Beyond the preview
Go deeper on Jiajian Zhujingfang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiajian Zhujingfang.